These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 16014854

  • 1. Response of Plasmodium falciparum to cotrimoxazole therapy: relationship with plasma drug concentrations and dihydrofolate reductase and dihydropteroate synthase genotypes.
    Khalil IF, Rønn AM, Alifrangis M, Gabar HA, Jelinek T, Satti GM, Bygbjerg IC.
    Am J Trop Med Hyg; 2005 Jul; 73(1):174-7. PubMed ID: 16014854
    [Abstract] [Full Text] [Related]

  • 2. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [Abstract] [Full Text] [Related]

  • 3. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R, Basco LK.
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [Abstract] [Full Text] [Related]

  • 4. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.
    Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [Abstract] [Full Text] [Related]

  • 6. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S.
    J Postgrad Med; 2004 Dec; 50(1):17-20. PubMed ID: 15047993
    [Abstract] [Full Text] [Related]

  • 7. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE, Alifrangis M, Khalil IF, Bygbjerg IC, Masuadi EM, Elbashir MI, Giha HA.
    Malar J; 2007 Aug 08; 6():108. PubMed ID: 17686173
    [Abstract] [Full Text] [Related]

  • 8. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH.
    Am J Trop Med Hyg; 2006 Feb 08; 74(2):198-204. PubMed ID: 16474070
    [Abstract] [Full Text] [Related]

  • 9. Sequence variations in the genes encoding dihydropteroate synthase and dihydrofolate reductase and clinical response to sulfadoxine-pyrimethamine in patients with acute uncomplicated falciparum malaria.
    Basco LK, Tahar R, Keundjian A, Ringwald P.
    J Infect Dis; 2000 Aug 08; 182(2):624-8. PubMed ID: 10915101
    [Abstract] [Full Text] [Related]

  • 10. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
    Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U.
    Infect Genet Evol; 2004 Dec 08; 4(4):321-7. PubMed ID: 15374529
    [Abstract] [Full Text] [Related]

  • 11. Pyrimethamine/sulfadoxine combination in the treatment of uncomplicated falciparum malaria: relation between dihydropteroate synthase/dihydrofolate reductase genotypes, sulfadoxine plasma levels, and treatment outcome.
    Khalil I, Alifrangis M, Rønn AM, Gabar HA, Jelinek T, Satti GM, Bygbjerg IC.
    Am J Trop Med Hyg; 2002 Sep 08; 67(3):225-9. PubMed ID: 12408659
    [Abstract] [Full Text] [Related]

  • 12. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole.
    Khalil I, Rønn AM, Alifrangis M, Gabar HA, Satti GM, Bygbjerg IC.
    Am J Trop Med Hyg; 2003 May 08; 68(5):586-9. PubMed ID: 12812351
    [Abstract] [Full Text] [Related]

  • 13. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.
    Peek R, VAN Gool T, Panchoe D, Greve S, Bus E, Resida L.
    Am J Trop Med Hyg; 2005 Nov 08; 73(5):833-8. PubMed ID: 16282289
    [Abstract] [Full Text] [Related]

  • 14. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
    Krudsood S, Imwong M, Wilairatana P, Pukrittayakamee S, Nonprasert A, Snounou G, White NJ, Looareesuwan S.
    Trans R Soc Trop Med Hyg; 2005 Feb 08; 99(2):142-9. PubMed ID: 15607340
    [Abstract] [Full Text] [Related]

  • 15. Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members.
    Malamba SS, Mermin J, Reingold A, Lule JR, Downing R, Ransom R, Kigozi A, Hunt BM, Hubbard A, Rosenthal PJ, Dorsey G.
    Am J Trop Med Hyg; 2006 Sep 08; 75(3):375-80. PubMed ID: 16968909
    [Abstract] [Full Text] [Related]

  • 16. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S, Kheir A, Abdel-Muhsin AM, Al-Ghazali A, Nwakanma D, Swedberg G, Babiker HA.
    Infect Genet Evol; 2009 Sep 08; 9(5):778-83. PubMed ID: 19379843
    [Abstract] [Full Text] [Related]

  • 17. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J, Mwankusye S, Mduma S, Veiga MI, Kitua A, Tomson G, Petzold MG, Swedberg G, Gustafsson LL, Warsame M.
    Trans R Soc Trop Med Hyg; 2008 Feb 08; 102(2):137-42. PubMed ID: 18082233
    [Abstract] [Full Text] [Related]

  • 18. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
    Gebru-Woldearegai T, Hailu A, Grobusch MP, Kun JF.
    Am J Trop Med Hyg; 2005 Dec 08; 73(6):1131-4. PubMed ID: 16354825
    [Abstract] [Full Text] [Related]

  • 19. Mutations in dhfr in Plasmodium falciparum infections selected by chlorproguanil-dapsone treatment.
    Curtis J, Maxwell CA, Msuya FH, Mkongewa S, Alloueche A, Warhurst DC.
    J Infect Dis; 2002 Dec 15; 186(12):1861-4. PubMed ID: 12447777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.